OCRA’s program is available to eligible individuals who may be at increased risk for ovarian or gynecologic cancer, especially those with a family history, as well as those diagnosed with ovarian or gynecologic cancer who have not undergone recent genetic testing.

Eligible individuals can apply for a free at-home genetic testing kit from Color Health. After providing a saliva sample, results are analyzed to identify any hereditary cancer risks.

Yes. After approval, you’ll receive an at-home test. It’s simple to use and comes with instructions.

Yes. Certified genetic counselors will guide you through the results and offer personalized next steps, if needed.

The test is completely free to those who qualify.

Individuals with a family history of ovarian, breast, uterine, prostate, or colorectal cancer, especially those with known BRCA mutations or Ashkenazi Jewish ancestry, should consider genetic testing.

No. In addition to screening for inherited ovarian cancer risk, this free test also looks for genetic variants linked to inherited risk of uterine / endometrial, breast, colorectal, and prostate cancers. For example, it can detect changes in genes associated with uterine / endometrial cancer risk, such as those tied to Lynch syndrome (EPCAM, MLH1, MSH2, MSH6, PMS2) and PTEN hamartoma tumor syndrome (PTEN), among many others.

Absolutely. Men can carry and pass on genetic mutations like BRCA, which may increase cancer risk for themselves and their offspring.

There is no at-home test that can diagnose ovarian cancer. However, you can screen for inherited genetic risk from home. OCRA’s free at-home genetic test kit screens for BRCA mutations, Lynch syndrome, and other genetic variants linked to increased ovarian cancer risk. Knowing your risk through genetic testing can help you and your doctor take preventive steps before symptoms ever appear.

If a mutation is found, genetic counselors can guide you through understanding your risk and discuss preventive measures, including increased surveillance, prophylactic surgery, or other treatment options.

The Hereditary Cancer Genetic Test analyzes 29 genes linked to inherited cancer risk: APC, ATM, BAP1, BARD1, BMPR1A, BRCA1, BRCA2, BRIP1, CDH1, CDK4, CDKN2A (p14ARF), CDKN2A (p16INK4a), CHEK2, EPCAM, GREM1, MITF, MLH1, MSH2, MSH6, MUTYH, PALB2, PMS2, POLD1, POLE, PTEN, RAD51C, RAD51D, SMAD4, STK11, and TP53. These genes are associated with hereditary risks for common cancers, including breast, colorectal, uterine, ovarian, prostate, and more